Release Date: 05/01/22 10:37 Summary: Change of Director's Interest Notice x2 Price Sensitive: No Download Document 377.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%